Security Snapshot

ETFIS SER TR I - VIRTUS BIOTECH C (BBC) Institutional Ownership

CUSIP: 26923G301

13F Institutional Holders and Ownership History from Q4 2014 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

20

Shares (Excl. Options)

295,990

Price

$41.62

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+23,106
Value change
+$1,087,023
Number of holders
20
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$54.87
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • BBC - ETFIS SER TR I - VIRTUS BIOTECH C is tracked under CUSIP 26923G301.
  • 20 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 20 to 4 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $12,341,692 to $4,007,764.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 20 institutions filings for Q1 2026.

Open SEC evidence

Security key

26923G301

Latest holder period

Q1 2026

13F holders

20

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 20 institutional investors reported holding 295,990 shares of ETFIS SER TR I - VIRTUS BIOTECH C (BBC).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
47
Latest
Q1 2026
Rows shown
1-25 of 47
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 75,446 $4,007,764 +$3,374,227 $52.69 4
2026 Q1 295,990 $12,341,692 +$1,087,023 $41.62 20
2025 Q4 258,484 $10,160,400 +$4,433,849 $38.56 19
2025 Q3 149,605 $4,082,535 +$1,669,393 $27.30 12
2025 Q2 88,703 $1,713,749 +$733,293 $19.32 11
2025 Q1 53,618 $940,472 -$574,730 $17.54 9
2024 Q4 70,195 $1,680,661 -$1,100,195 $23.94 9
2024 Q3 110,184 $3,078,190 -$29,572 $27.94 13
2024 Q2 111,250 $2,810,097 +$975,120 $25.26 14
2024 Q1 72,424 $2,109,134 -$1,089,268 $29.13 17
2023 Q4 115,959 $2,835,501 +$1,236,487 $24.45 18
2023 Q3 64,747 $1,270,270 -$1,076,040 $19.62 16
2023 Q2 111,527 $2,672,638 +$495,967 $23.96 17
2023 Q1 90,845 $1,992,717 -$3,684,483 $21.92 16
2022 Q4 240,775 $6,017,026 -$47,619 $24.99 18
2022 Q3 242,851 $5,965,596 +$530,235 $24.57 15
2022 Q2 221,359 $4,782,098 -$927,650 $21.60 13
2022 Q1 256,313 $7,163,416 -$1,129,662 $27.95 15
2021 Q4 294,894 $11,364,285 -$1,498,237 $38.58 18
2021 Q3 331,509 $15,151,299 +$763,538 $45.71 20
2021 Q2 314,414 $15,700,850 -$4,749,022 $49.94 18
2021 Q1 406,644 $20,884,051 +$980,459 $51.38 21
2020 Q4 383,198 $18,992,679 -$1,607,850 $49.58 19
2020 Q3 415,582 $16,199,156 -$467,383 $38.98 18
2020 Q2 421,289 $18,196,751 +$2,185,804 $43.19 19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .